RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 660 filers reported holding RAYTHEON CO in Q2 2013. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,913,000 | +3.5% | 11,847 | -2.3% | 0.22% | +1.9% |
Q1 2017 | $1,849,000 | +5.3% | 12,128 | -1.9% | 0.22% | -1.8% |
Q4 2016 | $1,756,000 | -1.1% | 12,367 | -5.2% | 0.22% | -6.0% |
Q3 2016 | $1,775,000 | +2.7% | 13,041 | +2.6% | 0.23% | -2.1% |
Q2 2016 | $1,728,000 | +14.1% | 12,713 | +2.9% | 0.24% | +11.7% |
Q1 2016 | $1,515,000 | +152.1% | 12,357 | +155.8% | 0.21% | +135.2% |
Q4 2015 | $601,000 | +19.2% | 4,830 | +4.7% | 0.09% | +13.8% |
Q3 2015 | $504,000 | +30.6% | 4,612 | +14.3% | 0.08% | +40.4% |
Q2 2015 | $386,000 | -5.2% | 4,034 | +8.4% | 0.06% | -5.0% |
Q1 2015 | $407,000 | -1.7% | 3,721 | -2.7% | 0.06% | +1.7% |
Q4 2014 | $414,000 | +13.7% | 3,824 | +6.8% | 0.06% | +3.5% |
Q3 2014 | $364,000 | -70.1% | 3,580 | -72.9% | 0.06% | -68.7% |
Q2 2014 | $1,218,000 | +14.4% | 13,204 | +22.5% | 0.18% | -8.5% |
Q1 2014 | $1,065,000 | +3.2% | 10,782 | -5.3% | 0.20% | +3.6% |
Q4 2013 | $1,032,000 | +17.7% | 11,380 | +0.0% | 0.19% | +7.9% |
Q3 2013 | $877,000 | +33.5% | 11,379 | +14.6% | 0.18% | +24.5% |
Q2 2013 | $657,000 | – | 9,931 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |